Skip to content

Clinical trials

Phase 3 Esophageal Neoplasms trials in France

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Esophageal Neoplasms Phase: Phase 3 Country / region: France Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20061
20101
20131
20161
20172
20181
20211
20221
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting2
Unknown status2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca1
Cancer Trials Ireland1
Centre Hospitalier Lyon Sud1
Centre Oscar Lambret1
Federation Francophone de Cancerologie Digestive1
Gustave Roussy, Cancer Campus, Grand Paris1
Innovent Biologics (Suzhou) Co. Ltd.1
Jazz Pharmaceuticals1
Merck Sharp & Dohme LLC1
Swiss Cancer Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Esophageal Neoplasms13
Stomach Neoplasms5
Esophageal Squamous Cell Carcinoma4
Adenocarcinoma1
Bile Duct Neoplasms1
Carcinoma, Squamous Cell1
Esophageal Diseases1
Gastrointestinal Diseases1
Laryngeal Neoplasms1
Mouth Neoplasms1

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.